Weiss Multi-Strategy Advisers’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,000	Closed	-$243K	–	764
2019 Q3	$243K	Buy	+5,000	New	+$261K	﹤0.01%	535

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GBT Position: Q4 2022 in Review

Weiss Multi-Strategy Advisers sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 66,052 shares — an estimated $4.5M sold.

Weiss Multi-Strategy Advisers first reported a position in GBT in Q4 2017 and held it in 17 quarters. The position peaked at $4.5M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Weiss Multi-Strategy Advisers reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 66,052 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $4.5M.
Weiss Multi-Strategy Advisers first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 17 quarters.
Weiss Multi-Strategy Advisers's Global Blood Therapeutics, Inc. position peaked at $4.5M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.